MedTrace Logo

OxyNorm Capsules in Post-Operative Pain Study

NCT01675635 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2018-02-26

Study results available
· View outcomes & findings →

Summary

The efficacy and safety of oxycodone capsules compared with morphine tablets in hospitalized patients with moderate to severe pain following surgery.

Conditions

  • Postoperative Pain

Interventions

DRUG

OxyNorm Capsules

dosage:5mg,l0mg and 20mg dosage form:capsule frequency:every 6h, duration:24 hours

OTHER

Morphine tablet

dosage: 10mg and 20mg; dosage form: tablet; frequency: every 6h; duration: 24 hours.

Sponsors & Collaborators

  • Mundipharma (China) Pharmaceutical Co. Ltd

    lead INDUSTRY

Principal Investigators

  • XinMin Wu, Prof. · Peking University 1st Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-06-30
Completion
2012-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01675635 on ClinicalTrials.gov